Prasanta K. Biswas

Dhaka, C 1212, Bangladesh

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh.

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh.

Journal: Vaccines
Published: May 19, 2026

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Journal: EClinicalMedicine
Published: September 15, 2025

Evaluating the effectiveness of COVID-19 vaccines during a period of Omicron variant predominance among Bangladeshi population: A test-negative design measurement.

Evaluating the effectiveness of COVID-19 vaccines during a period of Omicron variant predominance among Bangladeshi population: A test-negative design measurement.

Journal: Human vaccines & immunotherapeutics
Published: June 28, 2025

Prevalence of Shigellosis among household contacts of index cases in the EFGH catchment area, Dhaka, Bangladesh.

Prevalence of Shigellosis among household contacts of index cases in the EFGH catchment area, Dhaka, Bangladesh.

Journal: PLoS neglected tropical diseases
Published: May 20, 2025

Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model.

Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model.

Journal: Microbiome
Published: January 03, 2025

Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis.

Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against Vibrio cholerae in Bangladesh: an interim analysis.

Journal: BMJ global health
Published: June 14, 2024

5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.

5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial.

Journal: Lancet (London, England)
Published: April 26, 2024

The Enterics for Global Health (EFGH) Shigella Surveillance Study in Bangladesh.

The Enterics for Global Health (EFGH) Shigella Surveillance Study in Bangladesh.

Journal: Open forum infectious diseases
Published: March 27, 2024

Data Management in Multicountry Consortium Studies: The Enterics For Global Health (EFGH) Shigella Surveillance Study Example.

Data Management in Multicountry Consortium Studies: The Enterics For Global Health (EFGH) Shigella Surveillance Study Example.

Journal: Open forum infectious diseases
Published: March 27, 2024

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.

Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.

Journal: Frontiers in immunology
Published: October 09, 2023

Rebuttal to the Editor's letter related to "Cost-effective remedial to microfiber pollution from wash effluent in Kolkata and Ranaghat".

Rebuttal to the Editor's letter related to "Cost-effective remedial to microfiber pollution from wash effluent in Kolkata and Ranaghat".

Journal: Chemosphere
Published: September 20, 2023

Challenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study.

Challenges for maintaining post elimination phase of visceral leishmaniasis control programme in India: A field-based study.

Journal: PLoS neglected tropical diseases
Published: September 02, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026